Physician profile
Ali Ebrahim
NPI 1003344656
$342.95
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.88 · 2023: $126 · 2024: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $95.03 | 2023-2024 | Qutenza |
| Abbvie INC. | $42.45 | 2023-2024 | Qulipta |
| Lundbeck LLC | $41.74 | 2023 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $27.96 | 2022-2023 | Austedo Xr |
| Alexion Pharmaceuticals, INC. | $24.23 | 2022 | |
| Grt US Holding, INC. | $22.88 | 2022 | |
| Microtransponder, INC. | $19.56 | 2024 | |
| Sumitomo Pharma America, INC. | $18.35 | 2023 | Aptiom |
| Neurocrine Biosciences, INC. | $17.67 | 2024 | Ingrezza |
| Mallinckrodt Hospital Products INC. | $16.58 | 2024 | Acthar |
| Mdd US Operations, LLC | $16.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ebrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.